Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage
This study is currently recruiting participants.
Study NCT00722475   Information provided by Rigshospitalet, Denmark
First Received: July 23, 2008   Last Updated: February 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Secondary Recurrent Miscarriage
Additional conditions recognized in this trial
Abortion, Habitual
Abortion, Spontaneous
Neoplasm Metastasis
Recurrence
More general conditions related to this trial
Disease Attributes
Neoplasms
Neoplastic Processes
Pathologic Processes
Pregnancy Complications
Interventions listed in this trial
Intravenous immunoglobulin
Human albumin
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Rigshospitalet, Denmark
The Ministry of Science, Technology and Innovation, Denmark


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services